Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 1303 for “"Cisplatin"”.

  1. Nephrotoxicity of cisplatin

    … the most dangerous toxicities that results from cisplatin (CP), a chemotherapeutic agent. While AKI is a common occurrence amongst people who receive cisplatin (CP-AKI), the current risk assessment, intervention methods and understanding the role of magnesium in AKI, are either limited or …

    bu Repository record for Nephrotoxicity of cisplatin (opens in a new tab)

  2. Electrostatic Denaturation of DNA-Cisplatin Adducts

    … these techniques were applied toward detecting cisplatin interactions on a DNA surface. Depending on the surface coverage, cisplatin changes DNA stability accordingly.

    usfca Repository record for Electrostatic Denaturation of DNA-Cisplatin Adducts (opens in a new tab)

  3. Effects of cisplatin administration during pregnancy

    Cisplatin administration during pregnancy may pose risk to the child including congenital malformations and thus the foetus must be checked throughout chemotherapeutic administration. This systematic review was conducted using PubMed where clinical and pre-clinical articles were found. This study …

    kent Download PDF for Effects of cisplatin administration during pregnancy (opens in a new tab)

  4. Mitigating cisplatin resistance in ovarian cancer.

    … investigate the effect of a novel combination of cisplatin, sodium arsenite (NaAs02) and hyperthermia (CPA 39 DC) on EOC cells with different p53 status. Human EOC cells were treated with cisplatin ± 20 IJM NaAs02 for 1 h at 37 or 39°C. NaAs02 ± hyperthermia selectively sensitized wild-type p53 …

    louisville Repository record for Mitigating cisplatin resistance in ovarian cancer. (opens in a new tab)

  5. Cannabinoid Modulation Of Cisplatin Induced Neuropathy

    … or preventing tactile allodynia associated with cisplatin-administration. Mice (c57bl/6) were given eight doses of 2.3 mg/kg cisplatin or saline solution ip every second day to induce tactile allodynia (ringers on alternate days). Tactile responses to hind-paws were quantified in g of force using …

    mississippi Repository record for Cannabinoid Modulation Of Cisplatin Induced Neuropathy (opens in a new tab)

  6. Cisplatin-induced cytotoxicity in MDCK cells.

    Background. The mechanism of cisplatin-induced nephrotoxicity is not well understood. The distal tubules are affected in both human and animal studies, although the majority of cisplatin-induced renal damage is in proximal tubules. Platinum (Pt) forms intra- and interstrand cross-links with DNA in …

    ottawa-retro Repository record for Cisplatin-induced cytotoxicity in MDCK cells. (opens in a new tab)

  7. ATF3 as a Key Regulator of Cisplatin Cytotoxicity: Combining ATF3 Inducing Agents Enhances Cisplatin Activity in NSCLC

    … wide variety of stressors, as a key regulator of cisplatin cytotoxicity as well. Thus, enhanced and sustained induction of ATF3 by combining platins with other ATF3 inducers potentially represents an effective therapeutic strategy. A chemical library screen identified vorinostat and topotecan as …

    ottawa-retro Repository record for ATF3 as a Key Regulator of Cisplatin Cytotoxicity: Combining ATF3 Inducing Agents Enhances Cisplatin Activity in NSCLC (opens in a new tab)

  8. The pharmacogenomics of cisplatin-induced hearing loss

    Cisplatin is a widely used chemotherapeutic agent for the treatment of solid tumours. A serious complication of cisplatin treatment is permanent hearing loss. The study hypothesis is that genetic variants in genes involved in drug metabolism and transport can contribute to increased susceptibility …

    ubc Repository record for The pharmacogenomics of cisplatin-induced hearing loss (opens in a new tab) Download PDF for The pharmacogenomics of cisplatin-induced hearing loss (opens in a new tab)

  9. Cisplatin@US-tube Carbon Nanocapsules for Enhanced

    … of cancer. In particular, the encapsulation of cisplatin (CDDP), a widely-used anticancer drug, within US-tubes has been achieved by a loading procedure that is reproducible, and the resulting CDDP@US-tube material characterized by high-resolution transmission electron microscopy (HR-TEM), …

    rice Repository record for Cisplatin@US-tube Carbon Nanocapsules for Enhanced (opens in a new tab)

  10. Cellular responses to ionizing radiation and cisplatin.

    … the hypothesis that the synergistic effect of cisplatin in combination with radiation was due to cisplatin inhibition of repair of radiation-induced DNA damage. Two model cell systems were used. DNA repair inhibition caused by cisplatin and the fundamental mechanism of DNA double strand break …

    ottawa-retro Repository record for Cellular responses to ionizing radiation and cisplatin. (opens in a new tab)

  11. Embryotoxicity of cisplatin in rats and mice

    Thesis (M.S.)--Michigan State University. Department of Zoology, 1982

    msu Repository record for Embryotoxicity of cisplatin in rats and mice (opens in a new tab)

  12. The effects of cisplatin on carbohydrate metabolism

    Thesis (Ph. D.)--Michigan State University. Department of Food Science and Human Nutrition, 1982

    msu Repository record for The effects of cisplatin on carbohydrate metabolism (opens in a new tab)

  13. Effects of cisplatin on the rat neurohypophysis

    Thesis (M.S.)--Michigan State University. Interdepartmental Biological Sciences Program, 1986

    msu Repository record for Effects of cisplatin on the rat neurohypophysis (opens in a new tab)

  14. Thermosensitive Liposome Formulation of Cisplatin for Cancer Treatment

    Cisplatin (CDDP) is a platinum-based antineoplastic drug that is approved by the U.S. Food and Drug Administration (FDA) and Health Canada for treatment of many cancers. However, CDDP is associated with severe toxicities, including nephrotoxicity, gastrointestinal toxicity, and neurological …

    toronto-retro Repository record for Thermosensitive Liposome Formulation of Cisplatin for Cancer Treatment (opens in a new tab)

  15. Understanding cisplatin drug resistance in human ovarian cancer

    This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).

    iupui Repository record for Understanding cisplatin drug resistance in human ovarian cancer (opens in a new tab)

  16. DNA Damage Recognition and p53 in Cisplatin Resistance

    Cis-dichlorodiammineplatinum(II) (cisplatin) is widely used as an anti-cancer agent to treat various tumours particularly ovarian, testicular, bladder cancers and tumours of the head and neck. Although the precise mechanism of cisplatin-mediated cytotoxicity remains elusive, DNA damage is thought …

    glasgow Download PDF for DNA Damage Recognition and p53 in Cisplatin Resistance (opens in a new tab)

Page 1 of 66